China

Latest News and Resources

CDMO News

CPC Scientific Completes FDA Pre-License Inspection for Hepcludex® API Manufacturing

6 August 2026

CDMO News

Altruist Biologics Completes First Commercial PPQ Campaign on 20,000L Bioreactors

6 August 2026

CDMO News

Porton Advanced Secures China Drug Manufacturing License for Commercial CGT CDMO Services

6 August 2026

CDMO News

AsymBio Secures 1.2397 Billion(approximately $184 million) Yuan to Expand Biologics CDMO Capacity

5 August 2026

CDMO News

AsymBio Breaks Ground on New Shanghai Biologics R&D Building

28 July 2026

CDMO News

Asymchem’s Carbapenem API Facility Passes First USFDA Pre-Approval Inspection

27 July 2026

CDMO News

WuXi Biologics Reaches 1,000th Molecule Milestone Through Earendil Labs Collaboration

21 July 2026

Chart

A Category 5 Super Typhoon Is Tracking Toward 630 China and Taiwan Pharma Manufacturing Sites

8 July 2026

Policy Briefing

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

4 June 2026

Content

China Biopharma Out-Licensing Surges to Record $137.7B in 2025, 2026 on Pace to Break It Again

20 February 2026